![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 17
Zeitschriftenartikel
Predehl, P.; Andritschke, R.; Arefiev, V.; Babyshkin, V.; Batanov, O.; Becker, W.; Boehringer, H.; Bogomolov, A.; Boller, T.; Borm, K.; Bornemann, W.; Braeuninger, H.; Brueggen, M.; Brunner, H.; Brusa, M.; Bulbul, E.; Buntov, M.; Burwitz, V.; Burkert, W.; Clerc, N.; Churazov, E.; Coutinho, D.; Dauser, T.; Dennerl, K.; Doroshenko, V.; Eder, J.; Emberger, V.; Eraerds, T.; Finoguenov, A.; Freyberg, M.; Friedrich, P.; Friedrich, S.; Fuermetz, M.; Georgakakis, A.; Gilfanov, M.; Granato, S.; Grossberger, C.; Gueguen, A.; Gureev, P.; Haberl, F.; Haelker, O.; Hartner, G.; Hasinger, G.; Huber, H.; Ji, L.; Kienlin, A. V.; Kink, W.; Korotkov, F.; Kreykenbohm, I.; Lamer, G.; Lomakin, I.; Lapshov, I.; Liu, T.; Maitra, C.; Meidinger, N.; Menz, B.; Merloni, A.; Mernik, T.; Mican, B.; Mohr, J.; Mueller, S.; Nandra, K.; Nazarov, V.; Pacaud, F.; Pavlinsky, M.; Perinati, E.; Pfeffermann, E.; Pietschner, D.; Ramos-Ceja, M. E.; Rau, A.; Reiffers, J.; Reiprich, T. H.; Robrade, J.; Salvato, M.; Sanders, J.; Santangelo, A.; Sasaki, M.; Scheuerle, H.; Schmid, C.; Schmitt, J.; Schwope, A.; Shirshakov, A.; Steinmetz, M.; Stewart, I.; Strueder, L.; Sunyaev, R.; Tenzer, C.; Tiedemann, L.; Truemper, J.; Voron, V.; Weber, P.; Wilms, J. und Yaroshenko, V.
(2021):
The eROSITA X-ray telescope on SRG.
In: Astronomy & Astrophysics, Bd. 647, A1
Merle, M.; Fischbacher, D.; Liepert, A.; Grabrucker, C.; Kroell, T.; Kremser, A.; Dreyssig, J.; Freudenreich, M.; Schuster, F.; Borkhardt, A.; Kraemer, D.; Koehne, C-H; Kolb, H. J.; Schmid, C. und Schmetzer, H. M.
(2021):
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.
In: Immunobiology, Bd. 226, Nr. 3, 152088
Merle, M.; Fischbacher, D.; Liepert, A.; Grabrucker, C.; Kroell, T.; Kremser, A.; Dreyssig, J.; Freudenreich, M.; Schuster, F.; Borkhardt, A.; Krämer, D.; Koehne, C-H; Kolb, H. J.; Schmid, C. und Schmetzer, H. M.
(2019):
Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.
In: Immunological Investigations, Bd. 49, Nr. 4: S. 365-385
Craddock, C.; Versluis, J.; Labopin, M.; Socie, G.; Huynh, A.; Deconinck, E.; Volin, L.; Milpied, N.; Bourhis, J. H.; Rambaldi, A.; Chevallier, P.; Blaise, D.; Manz, M.; Vellenga, E.; Vekemans, M-C.; Maertens, J.; Passweg, J.; Vyas, P.; Schmid, C.; Lowenberg, B.; Ossenkoppele, G.; Mohty, M.; Cornelissen, J. J. und Nagler, A.
(2018):
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.
In: Journal of Internal Medicine, Bd. 283, Nr. 4: S. 371-379
Ringden, O.; Labopi, M.; Sadeghi, B.; Mailhol, A.; Beelen, D.; Floisand, Y.; Ghavamzadeh, A.; Finke, J.; Ehninger, G.; Volin, L.; Socie, G.; Kröger, N.; Stuhler, G.; Ganser, A.; Schmid, C.; Giebel, S.; Mohty, M. und Nagler, A.
(2018):
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
In: Journal of Internal Medicine, Bd. 283, Nr. 2: S. 166-177
Tischer, Johanna; Zoellner, A. K.; Prevalsek, D.; Köhnke, T.; Fritsch, S.; Schulz, C.; Lippl, S.; Kruger, S.; Haebe, S.; Berking, S.; Fraccaroli, A.; Ledderose, G.; Spiekermann, K.; Bug, G.; Hausmann, A.; Schmid, C.; Albert, M. und Hiddemann, W.
(2017):
Haploidentical Stem Cell Transplantation in ALL.
In: Annals of Hematology, Bd. 96:
S39-S40
Ringden, O.; Labopin, M.; Schmid, C.; Sadeghi, B.; Polge, E.; Tischer, J.; Ganser, A.; Michallet, M.; Kanz, L.; Schwerdtfeger, R.; Nagler, A. und Mohty, M.
(2016):
Sequential chemotherapy followed by reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia (AML): a survey from the Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S476-S477
Christopeit, M.; Tischer, J.; Schetelig, J.; Bornhäuser, M.; Uharek, L.; Wolff, D.; Holler, E.; Pfrepper, C.; Behre, G.; Niederwieser, D.; Kroeger, N.; Kobbe, G.; Weber, T.; Müller, L. P.; Rösler, W.; Klein, S.; Hausmann, A.; Beelen, D. W.; Bethge, W. und Schmid, C.
(2016):
Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 69 pts on behalf of the German Cooperative Transplant Group.
In: Oncology Research and Treatment, Bd. 39: S. 168
Pohlen, M.; Braess, J.; Thudium, J.; Schmid, C.; Kochanek, M.; Kreuzer, K.-A.; Görlich, D.; Gerth, U.; Rhode, C.; Müller-Tidow, C.; Stelljes, M.; Büchner, T.; Schlimok, G.; Hallek, M.; Waltenberger, J.; Hiddemann, W.; Berdel, W. E.; Heilmeier, B. und Krug, U.
(2016):
Patients with acute myeloid leukemia admitted to intensive care units: Scores predicting outcome and post-ICU survival.
In: Oncology Research and Treatment, Bd. 39: S. 51
Malard, F.; Labopin, M.; Stuhler, G.; Bittenbring, J.; Ganser, A.; Tischer, J.; Michallet, M.; Kroeger, N.; Schmid, C.; Huynh, A.; Hallek, M.; Savani, B.; Mohty, M. und Nagler, A.
(2016):
Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with high-risk AML in complete remission: a survey from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S11-S11
Inngjerdingen, M.; Rabe, A.; Deen, D.; Stankova, Z.; Hirn, A.; Tischer, J.; Schmid, C. und Schmetzer, H.
(2016):
Immunemodulation of AML-blasts with clinically approved response modifiers improves antileukemic T-cell reactivity ex vivo and leads to blast-reduction in vivo (rat-Modell).
In: Bone Marrow Transplantation, Bd. 51:
S474-S474
Baron, F.; Ruggeri, A.; Beohou, E.; Labopin, M.; Sanz, G.; Milpied, N.; Michallet, M.; Socie, G.; Blaise, D.; Sierra, J.; Cornelissen, J.; Mohty, M.; Schmid, C.; Giebel, S.; Gorin, N. C.; Esteve, J.; Ciceri, F.; Savani, B.; Gluckman, E. und Nagler, A.
(2016):
Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S278-S279
Tsirigotis, P.; Byrne, M.; Schmid, C.; Baron, F.; Ciceri, F.; Esteve, J.; Gorin, N. C.; Giebel, S.; Mohty, M.; Savani, B. N. und Nagler, A.
(2016):
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51, Nr. 11: S. 1431-1438
Jedlickova, Z.; Schmid, C.; Koenecke, C.; Hertenstein, B.; Baurmann, H.; Schwerdtfeger, R.; Tischer, J.; Kolb, H.-J. und Schleuning, M.
(2016):
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.
In: Bone Marrow Transplantation, Bd. 51, Nr. 5: S. 663-667
Schmid, C.; Schleuning, M.; Hentrich, M.; Markl, G. E.; Gerbitz, A.; Tischer, J.; Ledderose, G.; Oruzio, D.; Hiddemann, Wolfgang und Kolb, H. J.
(2008):
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
In: Bone Marrow Transplantation, Bd. 41, Nr. 8: S. 721-727
Schmid, C.; Schleuning, M.; Aschan, J.; Ringden, O.; Hahn, J.; Holler, E.; Hegenbart, U.; Niederwieser, D. W.; Dugas, Martin; Ledderose, G. und Kolb, H. J.
(2004):
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation [2].
In: Leukemia, Bd. 18, Nr. 8: S. 1430-1433
Eisenmenger, Wolfgang; Schmid, C. und Spann, W.
(1984):
Das Phänomen des "plötzlichen Kindstodes" aus sozialer und psychologischer Sicht.
In: Münchener medizinische Wochenschrift : MMW, Bd. 126, Nr. 25: S. 795-799
[PDF, 1MB]